Thu, 04 Aug|
Tinguely Museum Basel (at the Rhine)
SMPA Local Meeting: Basel
Rhine swimming and drink afterwards
Time & Location
04 Aug 2022, 18:00
Tinguely Museum Basel (at the Rhine), Paul Sacher-Anlage 2, 4002 Basel
About the event
We would like to invite you in the name of the Swiss MD-PhD Association (SMPA) to join us for our next local meeting this Thursday (August 4). We will meet at 6pm in front of the Tinguely Museum Basel (at the Rhine). We will go Rhine swimming together and have a drink afterwards. The first drink will be sponsored by the SMPA. Those who don’t want to join for Rhine swimming are welcome to join us later, around 7pm at a Buvette between Dreirosen- and Mittlere Brücke.
If you have medical student, MD or MD-PhD friends that are interested or are already involved in any kind of science do not hesitate to invite them and bring them along!
We're looking forward to seeing you!
Tanay Kaymak and Maurizio Cortada
SMPA local representatives Basel
Local meetings are informal networking events. Use this great opportunity to meet your colleagues at various stages of their scientific career, and to learn more about the SMPA and what it can do for you!
For questions and comments, contact us at email@example.com.
MEET THE KEYNOTE SPEAKERS
CEO Speransa Therapeutics
Topic: “From research to the vaccine vials”
Madiha has been working on vector engineering and vaccine design for over 17 years. She has a strong background in applied molecular and cellular biotechnology, in virology and in immunology, with research interests at the interface of fundamental and translational research, the so-called bench-to-bedside. She especially focuses on immune stimulation and immune modulation, both in the oncology and infectious disease fields.
Madiha holds a PhD in Biotechnology from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland and a Master in Biotechnology Engineering from the University of Technology of Berlin, Germany.
Madiha is also the Scientific Founder of AMAL Therapeutics, a Swiss biotech company developing first-in-class therapeutic cancer vaccines. She designed and characterized a CPP-based multi-epitopic cancer vaccine in the Laboratory of Tumour Immunology of the University of Geneva, which is the basis of the KISIMA proprietary vaccine platform. Madiha excitingly drove the integration of AMAL Therapeutics into the Boehringer Ingelheim.
SMPA Conference 2023 has been made possible thanks to the generous support of: